Affordable Access

Amelioration of radiation esophagitis by orally administered p53/Mdm2/Mdm4 inhibitor (BEB55) or GS-nitroxide.

Authors
Type
Published Article
Journal
In Vivo
1791-7549
Publisher
International Institute of Anticancer Research
Publication Date
Volume
25
Issue
6
Pages
841–848
Identifiers
PMID: 22021675
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments